Cure Parkinson’s and Alzheimer’s Research UK announce a partnership
Cure Parkinson’s and Alzheimer’s Research UK are working on an initiative that could pave the way for innovative neurodegenerative treatments. There is a growing recognition that tackling neurodegenerative diseases could benefit from a collaborative, cross-disease approach. We are recognising the overlap in underlying biological...
Learn more
Phase 2 respiratory drug for Parkinson’s has promise
13 January 2020 Results published today in The Journal of the American Medical Association (JAMA) Neurology Cure Parkinson’s is delighted to announce the publication of the results of a phase 2 clinical trial evaluating ambroxol as a potential treatment to slow the progression of Parkinson’s….